2Guan Z, Wang Y, Maoleekoonpairoj S, et al. Prospective random2 ised phase II study of gemcitabine at standard or fixed dose rate schedule in unresectable hepatocellular carcinoma[J]. Br J Canc2 er, 2003, 89(10): 1865-1869.
3Lee WP, Tai DI, Tsai SL, et al. Adenovirus type 5 EIA sensitizes hepatocellular carcinoma cells to gemcitabine[J]. Cancer Res, 2003, 63(19):6229-6236.
4Sarner M. Treatment of pancreatic exocrine deficiency[J]. World J Surg, 2003, 27(11):1192-1195.
